Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

High plasma level of fibroblast growth factor 21 is an Independent predictor of type 2 diabetes: a 5.4-year population-based prospective study in Chinese subjects.

Chen C, Cheung BM, Tso AW, Wang Y, Law LS, Ong KL, Wat NM, Xu A, Lam KS.

Diabetes Care. 2011 Sep;34(9):2113-5. doi: 10.2337/dc11-0294. Epub 2011 Jul 12.

2.

Plasma FGF21 displays a circadian rhythm during a 72-h fast in healthy female volunteers.

Andersen B, Beck-Nielsen H, Højlund K.

Clin Endocrinol (Oxf). 2011 Oct;75(4):514-9. doi: 10.1111/j.1365-2265.2011.04084.x.

PMID:
21521350
3.

Fibroblast growth factor 21: effects on carbohydrate and lipid metabolism in health and disease.

Kralisch S, Fasshauer M.

Curr Opin Clin Nutr Metab Care. 2011 Jul;14(4):354-9. doi: 10.1097/MCO.0b013e328346a326. Review.

PMID:
21505329
4.

Glucose and insulin measurements from the oral glucose tolerance test and relationship to muscle mass.

Kalyani RR, Metter EJ, Ramachandran R, Chia CW, Saudek CD, Ferrucci L.

J Gerontol A Biol Sci Med Sci. 2012 Jan;67(1):74-81. doi: 10.1093/gerona/glr022. Epub 2011 Feb 24.

5.

Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity.

Mashili FL, Austin RL, Deshmukh AS, Fritz T, Caidahl K, Bergdahl K, Zierath JR, Chibalin AV, Moller DE, Kharitonenkov A, Krook A.

Diabetes Metab Res Rev. 2011 Mar;27(3):286-97. doi: 10.1002/dmrr.1177.

PMID:
21309058
6.

Serum levels of FGF-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile.

Lin Z, Wu Z, Yin X, Liu Y, Yan X, Lin S, Xiao J, Wang X, Feng W, Li X.

PLoS One. 2010 Dec 29;5(12):e15534. doi: 10.1371/journal.pone.0015534.

7.

Obesity is a fibroblast growth factor 21 (FGF21)-resistant state.

Fisher FM, Chui PC, Antonellis PJ, Bina HA, Kharitonenkov A, Flier JS, Maratos-Flier E.

Diabetes. 2010 Nov;59(11):2781-9. doi: 10.2337/db10-0193. Epub 2010 Aug 3.

8.

Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1alpha pathway.

Chau MD, Gao J, Yang Q, Wu Z, Gromada J.

Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12553-8. doi: 10.1073/pnas.1006962107. Epub 2010 Jun 28.

9.

Fibroblast growth factor 21: from pharmacology to physiology.

Kliewer SA, Mangelsdorf DJ.

Am J Clin Nutr. 2010 Jan;91(1):254S-257S. doi: 10.3945/ajcn.2009.28449B. Epub 2009 Nov 11. Review.

10.

Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity.

Mraz M, Bartlova M, Lacinova Z, Michalsky D, Kasalicky M, Haluzikova D, Matoulek M, Dostalova I, Humenanska V, Haluzik M.

Clin Endocrinol (Oxf). 2009 Sep;71(3):369-75. doi: 10.1111/j.1365-2265.2008.03502.x. Epub 2008 Dec 11.

PMID:
19702724
11.

FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response.

Potthoff MJ, Inagaki T, Satapati S, Ding X, He T, Goetz R, Mohammadi M, Finck BN, Mangelsdorf DJ, Kliewer SA, Burgess SC.

Proc Natl Acad Sci U S A. 2009 Jun 30;106(26):10853-8. doi: 10.1073/pnas.0904187106. Epub 2009 Jun 16.

12.

Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance.

Chavez AO, Molina-Carrion M, Abdul-Ghani MA, Folli F, Defronzo RA, Tripathy D.

Diabetes Care. 2009 Aug;32(8):1542-6. doi: 10.2337/dc09-0684. Epub 2009 Jun 1.

13.

Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma-glutamyltransferase but not insulin sensitivity in Chinese subjects.

Li H, Bao Y, Xu A, Pan X, Lu J, Wu H, Lu H, Xiang K, Jia W.

J Clin Endocrinol Metab. 2009 Jun;94(6):2151-6. doi: 10.1210/jc.2008-2331. Epub 2009 Mar 24.

PMID:
19318452
14.

Serum levels of the adipokine FGF21 depend on renal function.

Stein S, Bachmann A, Lössner U, Kratzsch J, Blüher M, Stumvoll M, Fasshauer M.

Diabetes Care. 2009 Jan;32(1):126-8. doi: 10.2337/dc08-1054. Epub 2008 Oct 7.

15.

The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man.

Gälman C, Lundåsen T, Kharitonenkov A, Bina HA, Eriksson M, Hafström I, Dahlin M, Amark P, Angelin B, Rudling M.

Cell Metab. 2008 Aug;8(2):169-74. doi: 10.1016/j.cmet.2008.06.014.

16.

Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans.

Zhang X, Yeung DC, Karpisek M, Stejskal D, Zhou ZG, Liu F, Wong RL, Chow WS, Tso AW, Lam KS, Xu A.

Diabetes. 2008 May;57(5):1246-53. doi: 10.2337/db07-1476. Epub 2008 Feb 5.

17.

BetaKlotho is required for metabolic activity of fibroblast growth factor 21.

Ogawa Y, Kurosu H, Yamamoto M, Nandi A, Rosenblatt KP, Goetz R, Eliseenkova AV, Mohammadi M, Kuro-o M.

Proc Natl Acad Sci U S A. 2007 May 1;104(18):7432-7. Epub 2007 Apr 23.

18.

The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21.

Kharitonenkov A, Wroblewski VJ, Koester A, Chen YF, Clutinger CK, Tigno XT, Hansen BC, Shanafelt AB, Etgen GJ.

Endocrinology. 2007 Feb;148(2):774-81. Epub 2006 Oct 26.

PMID:
17068132
19.

FGF-21 as a novel metabolic regulator.

Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Micanovic R, Galbreath EJ, Sandusky GE, Hammond LJ, Moyers JS, Owens RA, Gromada J, Brozinick JT, Hawkins ED, Wroblewski VJ, Li DS, Mehrbod F, Jaskunas SR, Shanafelt AB.

J Clin Invest. 2005 Jun;115(6):1627-35. Epub 2005 May 2.

20.

Follow-up report on the diagnosis of diabetes mellitus.

Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P; Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.

Diabetes Care. 2003 Nov;26(11):3160-7. Review. No abstract available.

PMID:
14578255

Supplemental Content

Support Center